Philip Bedford

2.3k total citations
36 papers, 1.8k citations indexed

About

Philip Bedford is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Philip Bedford has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Infectious Diseases and 8 papers in Cancer Research. Recurrent topics in Philip Bedford's work include DNA Repair Mechanisms (7 papers), Mosquito-borne diseases and control (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Philip Bedford is often cited by papers focused on DNA Repair Mechanisms (7 papers), Mosquito-borne diseases and control (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Philip Bedford collaborates with scholars based in United Kingdom, United States and Germany. Philip Bedford's co-authors include Thomas P. Monath, Richard Nichols, Karen McCarthy, Bridget T. Hill, Farshad Guirakhoo, Sutee Yoksan, Casey Johnson, Sharon A. Shellard, Gerhard Eisenbrand and Louise K. Hosking and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Biochemistry and The Journal of Infectious Diseases.

In The Last Decade

Philip Bedford

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Bedford United Kingdom	23	882	819	494	208	185	36	1.8k
Rita G. Kansal United States	27	1.3k 1.5×	1.4k 1.6×	503 1.0×	247 1.2×	376 2.0×	50	2.5k
S. Swaminathan India	33	1.0k 1.2×	1.1k 1.4×	990 2.0×	149 0.7×	279 1.5×	76	2.6k
Arthur E. Franke United States	16	408 0.5×	181 0.2×	762 1.5×	86 0.4×	198 1.1×	19	1.4k
Ulrich von Pawel‐Rammingen Sweden	24	394 0.4×	587 0.7×	710 1.4×	91 0.4×	162 0.9×	32	1.7k
Céline Lacroix France	23	647 0.7×	407 0.5×	1.1k 2.2×	150 0.7×	420 2.3×	37	2.3k
Giovanni Faggioni Italy	18	513 0.6×	242 0.3×	578 1.2×	164 0.8×	80 0.4×	51	1.3k
Friedrich Dorner Austria	28	536 0.6×	178 0.2×	813 1.6×	98 0.5×	586 3.2×	115	3.0k
Stephen B. Aley United States	27	631 0.7×	1.0k 1.2×	673 1.4×	188 0.9×	242 1.3×	50	2.5k
Venkatakrishna Shyamala United States	23	397 0.5×	199 0.2×	805 1.6×	485 2.3×	770 4.2×	41	2.6k
Carleen Collins United States	22	318 0.4×	256 0.3×	414 0.8×	88 0.4×	144 0.8×	36	1.2k

Countries citing papers authored by Philip Bedford

Since Specialization

Citations

This map shows the geographic impact of Philip Bedford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bedford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bedford more than expected).

Fields of papers citing papers by Philip Bedford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Bedford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bedford. The network helps show where Philip Bedford may publish in the future.

Co-authorship network of co-authors of Philip Bedford

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Bedford. A scholar is included among the top collaborators of Philip Bedford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Bedford. Philip Bedford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monath, Thomas P., Niranjan Kanesa-thasan, Gwendolyn A. Myers, et al.. (2006). A live, attenuated recombinant West Nile virus vaccine. Proceedings of the National Academy of Sciences. 103(17). 6694–6699. 155 indexed citations

Guirakhoo, Farshad, Scott Kitchener, Dennis Morrison, et al.. (2006). Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All. Human Vaccines. 2(2). 60–67. 155 indexed citations

Johnson, Casey, Thomas P. Monath, Niranjan Kanesa-thasan, et al.. (2005). Exercise-Induced Serum Enzyme Elevations Confounding the Evaluation of Investigational Drug Toxicity: Report of Two Cases in a Vaccine Trial. Human Vaccines. 1(1). 24–29. 7 indexed citations

Hall, Eric R., Roger Randall, R. McKenzie, et al.. (2005). Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine. 24(18). 3709–3718. 36 indexed citations

Monath, Thomas P., Martín S. Cetron, Karen McCarthy, et al.. (2005). Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly. Human Vaccines. 1(5). 207–214. 65 indexed citations

Monath, Thomas P., Farshad Guirakhoo, Richard Nichols, et al.. (2003). Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen. The Journal of Infectious Diseases. 188(8). 1213–1230. 165 indexed citations

Sougioultzis, Stavros, Cynthia Lee, Mazen Alsahli, et al.. (2002). Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine. 21(3-4). 194–201. 44 indexed citations

Monath, Thomas P., Karen McCarthy, Philip Bedford, et al.. (2002). Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 20(7-8). 1004–1018. 164 indexed citations

Monath, Thomas P., Richard Nichols, W. Tad Archambault, et al.. (2002). Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.. American Journal of Tropical Medicine and Hygiene. 66(5). 533–541. 133 indexed citations

10.

Bleehen, N M, Hunter Newman, R Rampling, et al.. (1995). A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma. British Journal of Cancer. 72(3). 766–768. 9 indexed citations

11.

Ramsay, Jonathan, N M Bleehen, Ian F. Dennis, et al.. (1992). Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer. International Journal of Radiation Oncology*Biology*Physics. 22(4). 721–725. 4 indexed citations

12.

Counsell, C.J.R., et al.. (1991). Monitoring Metabolic Responses after Induction of Hypoxia in the KHT Tumour Using³¹P NMR Spectroscopy. International Journal of Radiation Biology. 60(1-2). 363–367. 2 indexed citations

13.

Hill, Bridget T., Sharon A. Shellard, Louise K. Hosking, Anne Marie J. Fichtinger-Schepman, & Philip Bedford. (1990). Enhanced dna repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. International Journal of Radiation Oncology*Biology*Physics. 19(1). 75–83. 47 indexed citations

14.

Hosking, Louise K., Richard D. H. Whelan, Sharon A. Shellard, Philip Bedford, & Bridget T. Hill. (1990). An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. Biochemical Pharmacology. 40(8). 1833–1842. 88 indexed citations

15.

Hill, Bridget T., Richard D. H. Whelan, Louise K. Hosking, et al.. (1990). Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation. Cancer Treatment Reviews. 17. 21–26. 8 indexed citations

16.

Bedford, Philip, et al.. (1988). Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.. PubMed. 321–8. 13 indexed citations

17.

Bedford, Philip, et al.. (1988). Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe. British Journal of Cancer. 57(3). 284–286. 22 indexed citations

18.

Bedford, Philip, et al.. (1987). Immunochemical detection of cis-platin-DNA adducts in human testicular and bladder tumour cell lines. British Journal of Cancer. 2 indexed citations

19.

Berger, Martin R., Philip Bedford, W. Jens Zeller, & Manfred Kaufmann. (1984). A comparative study of therapeutic activity, myelotoxicity and DNA damage in the bone marrow of mice after cyclophosphamide and ASTA Z 7557 (INN mafosfamide). Investigational New Drugs. 2(2). 181–186. 6 indexed citations

20.

Bedford, Philip & Brian W. Fox. (1982). Repair of DNA interstrand crosslinks after busulphan. Cancer Chemotherapy and Pharmacology. 8(1). 3–7. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact